21
Feb
22
Feb

Dublin

Presented by

IPHA IPHA
BPCI BPCI
NIBRT NIBRT

Event Sponsors

PWC PWC

Agency partners

Intertrade Ireland Intertrade Ireland

Pharma Patrons

AbbVie

AbbVie is a global research-based biopharmaceutical company formed in 2013. It delivers world-class discovery, production and supply of critical medicines. A modern biopharmaceutical business, AbbVie has a significant footprint in Ireland that’s focused on novel and breakthrough therapies for tough-to-treat diseases and unmet medical needs, with a reputation for quality.

In Ireland, AbbVie employs more than 600 people at five different manufacturing and commercial sites across the country.

AbbVie is committed to developing and manufacturing the cutting-edge therapies and innovations that hold the potential to improve health care worldwide. Meeting these ambitious health goals involves combining advanced science with deep knowledge of diseases and Ireland plays a central role across all stages across this process.

AbbVie harnesses and supports Irish expertise in complex chemical and biological R&D. The company tests discoveries through clinical trials involving Irish patients, doctors and centres. It supports the manufacturing of many of the medicines and delivery devices involved here in Ireland. In this way, Ireland contributes to every part of the medicine discovery process. This platform then provides AbbVie’s commercial team with the opportunity to make these new treatments rapidly accessible to Irish patients.


Eli Lilly

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Lilly has been in Ireland for over 35 years and employs over 1,000 people across a range of activities including biopharmaceutical manufacturing and commercialisation, global business services, marketing and sales.

At our manufacturing campus in Kinsale, Lilly employs over 700 people, making medicine using the most modern chemical synthesis & biotechnology manufacturing processes. Lilly Kinsale makes medicines for the treatment of illnesses across therapeutic areas including oncology, immunology and diabetes. Recently in Kinsale, Lilly CEO David Ricks opened an active ingredient continuous manufacturing facility, which is designed to manufacture the most innovative small molecule medicines that are currently in the company’s development pipeline. The company is also investing in a significant expansion to the biotechnology capacity at the site, which is targeted for completion in 2021.

Our global business solutions centre in Little Island, Co. Cork employs over 400 people providing centralised business services to the company globally, including travel services, financial services and medical information support. The centre is currently expanding operations to include a wide range of innovative new services and is in the process of constructing a new office block that will double the size of its existing footprint.

To learn more about Lilly, please visit us at www.lilly.com / www.lilly.ie


GE Healthcare

GE Healthcare's Life Sciences business is on a mission to accelerate an age of molecular and precision medicine by providing expertise, tools and solutions for a wide range of applications. To enable the development and manufacture of high-quality biopharmaceuticals, vaccines and biologics, such as insulin, the business provides products, technologies, customized technical and commercial services, as well as the design and construction of complete biomanufacturing solutions. In addition to their leadership in bioprocessing, the business also offers tools for the basic research of cells and proteins, drug discovery, cell therapy and regenerative medicine, as well as leading contrast, PET and nuclear medicine agents for diagnostic imaging to help doctors make more informed diagnoses for better patient outcomes. The company's mission is to help enable a new era of molecular and precision medicine by providing customers with the technology, insight and knowledge to guide them ever more quickly from better biological understanding to better clinical therapies.


Janssen

As part of the Johnson and Johnson Family of Companies in Ireland that employ nearly 3,000 people, Janssen are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology, haematology, immunology, neuroscience, infectious disease and cardiovascular and metabolic diseases. Driven by our commitment to patients, Janssen develops innovative products, services and healthcare solutions to help people throughout the world.

Janssen in Dublin employs over 60 people from a wide variety of backgrounds including sales, marketing, market access, communications, government affairs, medical affairs and health economics. Janssen Pharmaceuticals Sciences UC has been operating in Cork since 1981 manufacturing bulk active pharmaceutical ingredients in Little Island that are sold throughout the world to other Janssen and third party companies.

Janssen Sciences Ireland UC established its operation in Ringaskiddy in 2005. For more than 25 years we have been a global leader in the field of biomedicines, pioneering monoclonal antibody technology, a cutting-edge approach to producing medicines that launched a new generation of products to treat immune related diseases such as rheumatoid arthritis and plaque psoriasis. Our facility in Ringaskiddy is producing biomedicines for both the treatment of immune related diseases and new and innovative cancer treatments.


Mallinckrodt

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing. To learn more about Mallinckrodt, visit www.mallinckrodt.com.


MSD

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world's most challenging diseases. In Ireland, MSD employs approximately 1,600 people across our businesses in Carlow, Cork, Dublin and Tipperary, including manufacturing, R&D, commercial and marketing facilities in addition to global support services. A member of Guaranteed Irish, MSD is proud to be one of Ireland’s leading exporters. Many of the most widely used MSD medicines are developed by our teams in Ireland, with over half of MSD’s global top 20 products now manufactured here. MSD has a strong legacy in Ireland that stretches back over the last 50 years, and has seen the company invest over $2.5 billion in expanding and developing its facilities here. For further information please visit www.msd.ie


Pfizer

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of human medicinal products. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Pfizer’s business interests in Ireland are diverse. There is a manufacturing presence in Active Pharmaceutical Ingredients, Solid Dose Pharmaceuticals, Sterile Injectables, Vaccines and Biopharmaceuticals; Commercial Human Prescription and Consumer Health Businesses; Global Financial Services Centre and a Global Treasury Operation. Ireland is a leading manufacturing base for Pfizer globally, exporting to global markets. Total capital investment by the company in Ireland exceeds $7billion.


Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life



Close